eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
2/2013
vol. 12
 
Share:
Send email
Share:
abstract:
Review paper

Psoriasis and osteoporosis

Agnieszka Gerkowicz
,
Aldona Pietrzak
,
Adam Nogalski
,
Tomasz Lűbek
,
Bartłomiej Wawrzycki
,
Karolina Kowalczyk
,
Marta Makara-Studzińska
,
Grażyna Chodorowska
,
Tomasz Paszkowski

Przegląd Menopauzalny 2013; 2: 159–162
DOI: https://doi.org/10.5114/pm.2013.35078
Online publish date: 2013/05/13
View full text Get citation
 
PlumX metrics:
Hormones are known to be an important factor influencing many crucial physiological processes in the human body. Bone metabolism is a good example of such regulatory contribution of hormones. Sex hormones like estrogens and androgens, growth hormone or calcitonin support bone growth. On the other hand, parathormone and corticosteroids may induce osteoporosis. Osteoporosis is a systemic skeletal disease characterized by architectural deterioration of bone tissue and low bone mass, which results in increased bone fragility. Postmenopausal osteoporosis is the most common type of involutional osteoporosis. The connection between menopause and loss of bone mass has attracted attention of the scientific community for many years and has been intensively investigated. There is little known about influence of psoriasis on bone metabolism. Psoriasis is a chronic and relapsing skin disease with a population prevalence of 2-3%. It is characterized by immunological dysfunction, epidermal hyperproliferation, impaired differentiation of keratinocytes and excessive angiogenesis. In recent years, psoriasis has been recognized as a disease associated with systemic comorbidities. Data about the possible association between reduced mineral bone density and psoriasis are limited. Modern conceptions implying such connection are mainly based on common inflammatory factors like tumor necrosis factor α (TNF-α) or IL-6, which are involved in pathophysiology of both psoriasis and osteoporosis.
keywords:

osteoporosis, menopause, psoriasis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.